BrainStorm Cell Therapeutics executives attend DUPHAT conference, Pitts delivers keynotes

• BrainStorm will attend the DUPHAT pharmaceuticals conference in Dubai on Aug. 25-27, 2026.
• Executive Chairman Peter J. Pitts is scheduled to deliver two keynote addresses, including on FDA policy coordination tied to the Abraham Accords.
• Management plans regional meetings with regulators, distribution partners, investors to support NurOwn positioning ahead of a planned Phase 3b ENDURANCE trial.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brainstorm Cell Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608240815PR_NEWS_USPR_____IO32128) on August 24, 2026, and is solely responsible for the information contained therein.